NCT04650568View on ClinicalTrials.gov

Biologic Augmentation With Mesenchymal Stem Cells in Patients Undergoing Anterior Cruciate Ligament Reconstruction

NAEnrolling by invitationINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

November 3, 2017

Primary Completion Date

December 3, 2025

Study Completion Date

December 31, 2025

Conditions
Anterior Cruciate Ligament InjuryAnterior Cruciate Ligament Rupture
Interventions
DEVICE

Autologous Bone Marrow Derived Mesenchymal Stem Cells

Autologous Bone Marrow Derived Mesenchymal Stem Cells injected into the ACL allograft prior to graft implantation.

OTHER

Sham incision

Small incision over the site where bone marrow aspirate would have been obtained

Trial Locations (1)

60521

Rush University Medical Center, Chicago

All Listed Sponsors
lead

Rush University Medical Center

OTHER